Cybin Granted U.S. Patent For CYB003 Psilocybin Program
Wed, Dec 6
Cybin's new patent is expected to provide protection until 2041 and includes composition of matter claims for the company’s proprietary CYB003 novel psilocybin program. https://t.co/v0buQqhYBt
New patent provides IP protection until at least 2041. Cybin’s patent portfolio now includes 39 granted patents and over 170 pending applications.